KM might be the best executive to manage Vaskepa in Europe, but he has little or no experience in the U.S....KM has done as good a job in Europe as anyone could...Now Amarin needs to find to find a very experienced executive to manage Vascepa in the U.S....as KM frequently says..."The U.S. and Europe are very different markets"
IMO someone with a great deal of successful past experience in marketing in the U.S. and in dealing with the FDA is needed to lead Amarin's efforts in the U.S.
This is another reason for a BP to acquire Amarin.
News 
Market Data 
Discover 
